Quarterly report · Q2
2927.TEDINET S100QLNK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.4bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥23.0bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥678m | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥453m | 2021-09-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥708m | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥643m | 2021-09-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥616m | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥560m | 2021-09-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥414m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥735m | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥417m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥39.0bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥37.3bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥35.9bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.3bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥24.9bn | at 2022-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.9bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.4bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.8bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2021-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥397m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥314m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥791m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥924m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥774m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.46 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.01 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.33 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.84 | 2021-09-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.8 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.45 | 2022-09-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.08 | 2021-09-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.71 | 2021-09-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 32.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | revenue external | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | segment profit | 2022-09-01 → 2023-02-28 | −¥2m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥13m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | −¥121m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥940m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥103m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥933m |
| Otherother segments | revenue | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | revenue external | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | segment profit | 2021-09-01 → 2022-02-28 | −¥10m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥122m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥190m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥992m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥85m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-02-28 | ¥755m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 536
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 7326508000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 1064101000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 2816517000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | 697983000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OtherReportableSegmentsMember | 539688000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 12444800000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_OtherReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 7326508000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 1064101000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 2816517000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | 697983000 | JPY |
| Net sales | CurrentYTDDuration_OtherReportableSegmentsMember | 539688000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 12444800000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 940267000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 103468000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 12788000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | -121317000 | JPY |
| Operating income | CurrentYTDDuration_OtherReportableSegmentsMember | -1997000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 933209000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-04-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第43期第2四半期(自 2022年12月1日 至 2023年2月28日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社AFC-HDアムスライフサイエンス | |
| Company name in english cover page | FilingDateInstant | AFC-HD AMS Life Science Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長 淺 山 雄 彦 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)静岡県静岡市駿河区豊田三丁目6番36号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)054-281-0585(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役会長室長 南 方 茂 穂 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)静岡県静岡市駿河区豊田三丁目6番36号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)054-281-5238(直通) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役会長室長 南 方 茂 穂 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E01064 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 29270 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社AFC-HDアムスライフサイエンス | |
| Filer name in english | FilingDateInstant | AFC-HD AMS Life Science Co.,Ltd | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |